Showing results (11-20 of 47) with videos related to
Sort By:
Pageof 5
Lung Cancer (Amsterdam, Netherlands)|June 1, 2005
Asian ethnicity and adenocarcinoma histology continues to predict response to gefitinib in patients treated for advanced non-small cell carcinoma of the lung in North AmericaCheryl Ho, Nevin Murray, Janessa Laskin, et al.Lung Cancer (Amsterdam, Netherlands)|November 14, 2008
Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British ColumbiaChristopher W Lee, Nevin Murray, Helen Anderson, et al.European Urology|July 15, 2014
Efficacy of enzalutamide following abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer patientsArun A Azad, Bernhard J Eigl, R Nevin Murray, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2014
Less toxic chemotherapy improves uptake of all lines of chemotherapy in advanced non-small-cell lung cancer: a 10-year retrospective population-based reviewCheryl Ho, Katherine Ramsden, Yongliang Zhai, et al.American Journal of Clinical Oncology|February 8, 2006
A phase I dose finding study of cisplatin, gemcitabine, and weekly docetaxel for patients with advanced transitional cell cancerAnna Tinker, Eric Winquist, Christina Canil, et al.The Journal of Urology|November 11, 2005
Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British ColumbiaAbdulwahab J Al-Tourah, Nevin Murray, Chris Coppin, et al.Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Referral patterns in advanced non-small cell lung cancer: impact on delivery of treatment and survival in a contemporary population based cohortKrista Noonan, King Mong Tong, Janessa Laskin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Influence of sex on toxicity and treatment outcome in small-cell lung cancerSimron Singh, Wendy Parulekar, Nevin Murray, et al.Lung Cancer (Amsterdam, Netherlands)|November 28, 2008
Improved survival from lung cancer in British Columbia compared to Scotland-are different treatment rates the whole story?Sara C Erridge, Brian Murray, Linda Williams, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2010
Stage I non-small cell lung cancer (NSCLC) in patients aged 75 years and older: does age determine survival after radical treatment?David A Palma, Scott Tyldesley, Finbarr Sheehan, et al.Pageof 5